This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meyer-Puttlitz, B. Articles by von Deimling, A. Search for Related Content PubMed PubMed Citation Articles by Meyer-Puttlitz, B. Articles by von Deimling, A.

American Journal of Pathology, Vol 151, 853-857, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Molecular genetic analysis of giant cell glioblastomas

B Meyer-Puttlitz, Y Hayashi, A Waha, B Rollbrocker, J Bostrom, OD Wiestler, DN Louis, G Reifenberger and A von Deimling
Department of Neuropathology, University of Bonn Medical Center, Germany.

Glioblastomas (GBMs) are a heterogeneous group of tumors. Recently, distinct molecular genetic alterations have been linked to subgroups of patients with GBM. Giant cell (gc)GBMs are a rare variant of GBM characterized by a marked preponderance of multinucleated giant cells. Several reports have associated this entity with a more favorable prognosis than the majority of GBMs. To evaluate whether gcGBM may also represent a genetically defined subgroup of GBM, we analyzed a series of 19 gcGBMs for mutations in the TP53 gene for amplification of the EGFR and CDK4 genes and for homozygous deletions in the CDKN2A (p16/MTS1) gene. Seventeen of nineteen gcGBMs carried TP53 mutations whereas EGFR and CDK4 gene amplification was seen in only one tumor each and homozygous deletion of CDKN2A was not observed at all. The strikingly high incidence of TP53 mutations and the relative absence of other genetic alterations groups gcGBM together with a previously recognized molecular genetic variant of GBM (type 1 GBM). It is tempting to speculate that the better prognosis of gcGBM patients may result from the low incidence of EGFR amplification and CDKN2A deletion, changes known for their growth-promoting potential.

This article has been cited by other articles:

				E. N. Eskandar, J. S. Loeffler, A. M. O'Neill, G. J. Hunter, and D. N. Louis Case 33-2004 - A 34-Year-Old Man with a Seizure and a Frontal-Lobe Brain Lesion N. Engl. J. Med., October 28, 2004; 351(18): 1875 - 1882. [Full Text] [PDF]

				R. M. Reis, D. Konu-Lebleblicioglu, J. M. Lopes, P. Kleihues, and H. Ohgaki Genetic Profile of Gliosarcomas Am. J. Pathol., February 1, 2000; 156(2): 425 - 432. [Abstract] [Full Text] [PDF]

				P. Kleihues and H. Ohgaki Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors Toxicol Pathol, January 1, 2000; 28(1): 164 - 170. [Abstract] [PDF]

				M. Nozaki, M. Tada, H. Kobayashi, C.-L. Zhang, Y. Sawamura, H. Abe, N. Ishii, and E. G. Van Meir Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression Neuro-oncol, April 1, 1999; 1(2): 124 - 137. [Abstract] [PDF]

				P. Kleihues and H. Ohgaki Primary and secondary glioblastomas: From concept to clinical diagnosis Neuro-oncol, January 1, 1999; 1(1): 44 - 51. [Abstract] [PDF]